195 related articles for article (PubMed ID: 18555634)
1. Significant differences in drug susceptibility among species in the Candida parapsilosis group.
van Asbeck E; Clemons KV; Martinez M; Tong AJ; Stevens DA
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):106-9. PubMed ID: 18555634
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Moris DV; Melhem MSC; Martins MA; Souza LR; Kacew S; Szeszs MW; Carvalho LR; Pimenta-Rodrigues MV; Berghs HAM; Mendes RP
J Med Microbiol; 2012 Dec; 61(Pt 12):1758-1765. PubMed ID: 22956748
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.
Silva AP; Miranda IM; Lisboa C; Pina-Vaz C; Rodrigues AG
J Clin Microbiol; 2009 Aug; 47(8):2392-7. PubMed ID: 19494078
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Candida parapsilosis complex isolates.
de Toro M; Torres MJ; Maite R; Aznar J
Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
[TBL] [Abstract][Full Text] [Related]
8. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
[TBL] [Abstract][Full Text] [Related]
9. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.
Treviño-Rangel Rde J; Garza-González E; González JG; Bocanegra-García V; Llaca JM; González GM
Med Mycol; 2012 Oct; 50(7):781-4. PubMed ID: 22493945
[TBL] [Abstract][Full Text] [Related]
12. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
Cordeiro RA; Macedo RB; Teixeira CEC; Marques FJF; Bandeira TJPG; Moreira JLB; Brilhante RSN; Rocha MFG; Sidrim JJC
J Med Microbiol; 2014 Jul; 63(Pt 7):936-944. PubMed ID: 24722799
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
Szilágyi J; Földi R; Gesztelyi R; Bayegan S; Kardos G; Juhász B; Majoros L
Chemotherapy; 2012; 58(2):159-64. PubMed ID: 22626860
[TBL] [Abstract][Full Text] [Related]
14. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
[TBL] [Abstract][Full Text] [Related]
15. In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.
Cantón E; Espinel-Ingroff A; Pemán J; del Castillo L
Antimicrob Agents Chemother; 2010 May; 54(5):2194-7. PubMed ID: 20145083
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples.
Ataides FS; Costa CR; Souza LK; Fernandes Od; Jesuino RS; Silva Mdo R
Rev Soc Bras Med Trop; 2015; 48(4):454-9. PubMed ID: 26312937
[TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
18. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Gonçalves SS; Amorim CS; Nucci M; Padovan AC; Briones MR; Melo AS; Colombo AL
Clin Microbiol Infect; 2010 Jul; 16(7):885-7. PubMed ID: 19686280
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
Khan Z; Ahmad S; Joseph L; Chandy R; Theyyathel A
J Chemother; 2011 Apr; 23(2):97-101. PubMed ID: 21571626
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
Bonfietti LX; Martins MDA; Szeszs MW; Pukiskas SBS; Purisco SU; Pimentel FC; Pereira GH; Silva DC; Oliveira L; Melhem MSC
J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
